Literature DB >> 11790460

Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma.

Shinji Ogawa1, Tsunehisa Kaku, Hiroaki Kobayashi, Toshio Hirakawa, Yoshihiro Ohishi, Naoko Kinukawa, Hitoo Nakano.   

Abstract

Our purpose is to demonstrate the relationship between microvessel density (MVD), vascular cuffing (VC), vascular endothelial growth factor (VEGF) expression and clinicopathological parameters in ovarian cancer. Surgical specimens from 105 primary ovarian cancers were examined for vascularization and VEGF expression by immunohistochemical staining. The higher MVD group (MVD> or =70) and the positive VEGF group were associated with better progression-free survival only in early stages. The significant association of the MVD with better progression-free survival was recognized only in the patients with clear cell adenocarcinomas. The complete VC group showed a similar trend as MVD though there was no statistical difference. A multivariate analysis revealed MVD to correlate independently with progression-free survival. In ovarian carcinoma, MVD was found to be an independent prognostic factor. In addition, the higher MVD with clear cell adenocarcinoma had the better prognosis. The clinicopathological role of angiogenesis should be analyzed taking account of histologic type.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790460     DOI: 10.1016/s0304-3835(01)00754-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

Authors:  Lin Zhang; Nuo Yang; Jose-Ramon Conejo Garcia; Alisha Mohamed; Fabian Benencia; Stephen C Rubin; David Allman; George Coukos
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants.

Authors:  Smrithi Padmakumar; Neha N Parayath; Shantikumar V Nair; Deepthy Menon; Mansoor M Amiji
Journal:  J Control Release       Date:  2019-05-17       Impact factor: 9.776

Review 3.  Angiogenesis in epithelian ovarian cancer.

Authors:  E S Bamberger; C W Perrett
Journal:  Mol Pathol       Date:  2002-12

Review 4.  Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.

Authors:  José A García-Sáenz; Ana Custodio; Antonio Casado; José Antonio Vidart; Pluvio J Coronado; Miguel Martín; Sara López-Tarruella; Javier Puente; Cristina Fernández; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2011-02       Impact factor: 3.405

Review 5.  Angiogenesis and ovarian cancer.

Authors:  César Gómez-Raposo; Marta Mendiola; Jorge Barriuso; Enrique Casado; David Hardisson; Andrés Redondo
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

6.  In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer.

Authors:  Martin Pölcher; Christian Rudlowski; Nicolaus Friedrichs; Marieke Mielich; Tobias Höller; Mathias Wolfgarten; Kirsten Kübler; Reinhard Büttner; Walther Kuhn; Michael Braun
Journal:  BMC Cancer       Date:  2010-04-13       Impact factor: 4.430

7.  Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.

Authors:  A M Jubb; T Q Pham; A M Hanby; G D Frantz; F V Peale; T D Wu; H W Koeppen; K J Hillan
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

8.  Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma.

Authors:  Tina Mukherjee; Anupam Kumar; Meera Mathur; Tushar Kant Chattopadhyay; Ranju Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-08       Impact factor: 4.553

9.  Cytokines as Prognostic Biomarkers of Epithelial Ovarian Cancer (EOC): A Systematic Review and Meta-Analysis.

Authors:  Moh Nailul Fahmi; Heru Pradjatmo; Indwiani Astuti; Ricvan Dana Nindrea
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

10.  Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival.

Authors:  K Ino; K Shibata; H Kajiyama; E Yamamoto; T Nagasaka; A Nawa; S Nomura; F Kikkawa
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.